Rapid and Steady Achievements through
Concentration on core competencies
At Nippon Shinyaku, we focus on the fields in which we specialize, operating under the concept of supplying the market with ethical drugs that feature distinctive benefits in terms of efficacy, safety or quality of life (QOL).
To unify our R&D with sales strategies, we have determined our main R&D domains as diseases in the five diagnostic and treatment fields of urology, hematology, obstetrics & gynecology, otorhinolaryngology and orthopedics. Through our own drug production based on drug discovery research, licensing-in from other companies and PLCM, we aim to bring products to market that patients will consider to be beneficial as quickly as possible.
Our drug discovery research concentrates on our priority diagnostic and treatment fields centering on hematology and urology. By elucidating the causes of new diseases, we can focus on the speedy development of proprietary drugs that offer distinctive benefits. In addition, we proactively license in marketed products and development-stage products as a method of enhancing our product pipeline. Moreover, through our PLCM activities, we consider new indications and formulations for our existing products and development-stage products, seeking to maximize product value.
Overall, our goal is to contribute to society by supplying a stable source of high-quality products to the market. To achieve this goal, we clarify our R&D targets, allocating our business resources appropriately to drug discovery, in-licensing and PLCM.
- Research & Development
- R&D System
- International Developments
- Overseas Base & Overseas Subsidiary
- Main Products
- Main products by therapeutic field
Nippon Shinyaku's Foodstuffs Division was established in 1961. Since then, the division's staff have devoted their efforts to contributing to health through the provision of health-promoting food, while at the same time displaying the "venture spirit" in diversifying the Company's business into a new field utilizing its technical know-how in pharmaceuticals.The Foodstuffs Division's activities have grown steadily, and its products have come to be used in food processing, cooking, preservation, and hygiene. In 1996, the division embarked on the development of health foods, and the first major product marketed in this field was Garcinia Extract, an additive useful in dieting. We plan to conduct research actively from here on with the needs of the aging society in mind.
Yamashina Institute for Botanical Research
Nippon Shinyaku's first major product after its establishment was Santonin, a treatment for intestinal worms. The active ingredient of Santonin was obtained from a variety of mugwort, cultivation of which we started in 1934 at the Center's predecessor, the Yamashina Test Farm. Since then, a wide range of plants have been cultivated, and new varieties developed. Currently, some 3,000 species of plants possessing pharmacological properties are cultivated at the Center, where they are also on show to visitors.